From: Herbert Stein [mailto:firstname.lastname@example.org]
Sent: Sunday, March 02, 2014 9:13 AM
To: Stephen J. Hemsley – CEO, United Healthcare
Cc: Jonathan Blum, Deputy Administrator and Director for the Center of Medicare at the Centers for Medicare and Medicaid Services; Amy Larrick, Senior Advisor to the Principal Deputy Administrator Centers for Medicare & Medicaid
Subject: Do we have to run a benefit for Mr. Hemsley?
Dear Mr. Hemsley,
As I sit here pondering why one of the financially top paid executives in the U.S. lacks the compassion and understanding to help one of his subscribers re-obtain wellness or “Continuity of care” is beyond me. With the simple stroke of your pen or a brief telephone conversation directing one of your subordinates to make it happen you’d rather make this particular individual suffer and agonize over her future. Or do we have to run a benefit for Mr. Hemsley because 2012 was not up to his expectations?
Is it money that only rules the decision making from the skyboxes? It certainly can’t be the facts because the facts are VNS Therapy for your subscriber (the patient) after all these years is not experimental. It is not experimental as she or her attending physician would not request replacement surgery for an ineffective therapy (something I’d refer to as simple logic). It is not experimental after 14 years for my spouse or other of the long-term use patients who have obtained replacement surgery and are continuing to benefit from VNS Therapy. It is not experimental as told to your company in appeal letters that you have received from her attending physician. It is not experimental as can be told to you by all the attending physicians of those patients who have benefited from the therapy and continue to do so today.
It is successfully unique for this group of patients unlike any ineffective conventional therapy these patients have trialed over decades. VNS Therapy is unlike any of these other ineffective conventional therapies in that it truly works long-term despite the opinion of your unknowledgeable hired gun. VNS Therapy works 24/7/365 without the patient being compliant or forgetful with minimal to no side-effects for this group of patients.
Why not ask the professional opinions of the physicians attending to each and every of the patients who have chosen to continue with the VNS Therapy? You’d come up with an absolutely amazing statistic unheard of in the annals of treating patients with Major Depressive Disorder (MDD). 100% of these patients are benefiting from the therapy long-term and for continuous multiple years. No other therapy can demonstrate similar results for this patient population.
Do we really have to run a benefit for you Mr. Hemsley to make you understand after all these years VNS Therapy for these patients is not experimental. It truly is effective and benefits these formerly and severely depressed patients who have finally found relief for their illness?
Step up Mr. Hemsley and do what is morally right. In the long-term scheme of things your company will financially benefit and it will accrue to you. Give a life back to this individual!
Joyce and Herbert Stein
1008 Trailmore Lane
Weston, FL 33326-2816
NOTICE OF CONFIDENTIALITY / Disclaimer
Disclaimer: This E-Mail is covered by the Electronic Communications Privacy Act, 18 U.S.C. §§ 2510-2521 and is legally privileged. The information contained in this E-Mail is intended only for use of the individual or entity named above. If the reader of this message is not the intended recipient, or the employee or agent responsible for delivering it to the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If you receive this E-Mail in error, please notify the sender immediately at the email address and/or phone number above and delete the information from your computer. Please do not copy or use it for any purpose nor disclose its contents to any other person.
CONFIDENTIALITY NOTICE: This e-mail message including attachments, if any, is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail, destroy all copies of the original message, and do not disseminate it further. If you are the intended recipient but do not wish to receive communications through this medium, please advise the sender immediately.